|
1
|
Colmant HJ and Noltenius H: Pancreatic
encephalopathy. Med Klin. 72:2146–2154. 1977.(In German).
PubMed/NCBI
|
|
2
|
Zhang XP and Tian H: Pathogenesis of
pancreatic encephalopathy in severe acute pancreatitis.
Hepatobiliary Pancreat Dis Int. 6:134–140. 2007.PubMed/NCBI
|
|
3
|
Mentula P and Leppäniemi A: Position
paper: Timely interventions in severe acute pancreatitis are
crucial for survival. World J Emerg Surg. 9:152014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng L, Xue J, Jaffee EM and Habtezion A:
Role of immune cells and immune-based therapies in pancreatitis and
pancreatic ductal adenocarcinoma. Gastroenterology. 144:1230–1240.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Al Mofleh IA: Severe acute pancreatitis:
Pathogenetic aspects and prognostic factors. World journal of
gastroenterology. 14:675–684. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang H, Neuhöfer P, Song L, Rabe B,
Lesina M, Kurkowski MU, Treiber M, Wartmann T, Regnér S, Thorlacius
H, et al: IL-6 trans-signaling promotes pancreatitis-associated
lung injury and lethality. J Clin Invest. 123:1019–1031. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang X, Zhuang X, Wei R, Wang C, Xue X and
Mao L: Protective effects of Acanthopanax vs. Ulinastatin against
severe acute pancreatitis-induced brain injury in rats. Int
Immunopharmacol. 24:285–298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohkubo T, Shiojiri T and Matsunaga T:
Severe diffuse white matter lesions in a patient with pancreatic
encephalopathy. J Neurol. 251:476–478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Adler G, Hahn C, Kern HF and Rao KN:
Cerulein-induced pancreatitis in rats: Increased lysosomal enzyme
activity and autophagocytosis. Digestion. 32:10–18. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yin T, Peeters R, Liu Y, Feng Y, Zhang X,
Jiang Y, Yu J, Dymarkowski S, Himmelreich U, Oyen R and Ni Y:
Visualization, quantification and characterization of
caerulein-induced acute pancreatitis in rats by 3.0T clinical MRI,
biochemistry and histomorphology. Theranostics. 7:285–294. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marrache F, Tu SP, Bhagat G, Pendyala S,
Osterreicher CH, Gordon S, Ramanathan V, Penz-Osterreicher M, Betz
KS, Song Z and Wang TC: Overexpression of interleukin-1beta in the
murine pancreas results in chronic pancreatitis. Gastroenterology.
135:1277–1287. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Terao K, Wake H, Adachi N, Liu K,
Teshigawara K, Takahashi H, Mori S and Nishibori M: Histidine-rich
glycoprotein suppresses hyperinflammatory responses of lung in a
severe acute pancreatitis mouse model. Pancreas. 47:1156–1164.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cildir G, Low KC and Tergaonkar V:
Noncanonical NF-κB signaling in health and disease. Trends Mol Med.
22:414–429. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hayden MS and Ghosh S: NF-κB in
immunobiology. Cell Res. 21:223–244. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui X, Chang L, Li Y, Lv Q, Wang F, Lin Y,
Li W, Meade JD, Walden JC and Liang P: Trivalent soluble TNF
receptor, a potent TNF-alpha antagonist for the treatment
collagen-induced arthritis. Sci Rep. 8:73272018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao S, Mysler E and Moots RJ: Etanercept
for the treatment of rheumatoid arthritis. Immunotherapy.
10:433–445. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kovar FM, Marsik C, Cvitko T, Wagner OF,
Jilma B and Endler G: The tumor necrosis factor alpha-308 G/A
polymorphism does not influence inflammation and coagulation
response in human endotoxemia. Shock. 27:238–241. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sheng YQ, Li F and Qin ZH: TNF receptor 2
makes tumor necrosis factor a friend of tumors. Front Immunol.
9:11702018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Muniraj T, Gajendran M, Thiruvengadam S,
Raghuram K, Rao S and Devaraj P: Acute pancreatitis. Dis Mon.
58:98–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
National Research Council Committee for
the Update of the Guide for the C, Use of Laboratory A. The
National Academies Collection, . Reports funded by National
Institutes of Health. Th, editor: Guide for the Care and Use of
Laboratory Animals (Washington (DC)). National Academies Press (US)
National Academy of Sciences. 2011.
|
|
22
|
How to determine humane endpoints for
research animals. Lab Anim (NY). 45:192016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sano Y, Ito S, Yoneda M, Nagasawa K,
Matsuura N, Yamada Y, Uchinaka A, Bando YK, Murohara T and Nagata
K: Effects of various types of anesthesia on hemodynamics, cardiac
function, and glucose and lipid metabolism in rats. Am J Physiol
Heart Circ Physiol. 311:H1360–H1366. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pierozan P, Jernerén F, Ransome Y and
Karlsson O: The choice of euthanasia method affects metabolic serum
biomarkers. Basic Clin Pharmacol Toxicol. 121:113–118. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
NC3Rs Reporting Guidelines Working Group,
: Animal research: Reporting in vivo experiments: The ARRIVE
guidelines. J Physiol. 588:2519–2521. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Orabi AI, Shah AU, Ahmad MU, Choo-Wing R,
Parness J, Jain D, Bhandari V and Husain SZ: Dantrolene mitigates
caerulein-induced pancreatitis in vivo in mice. Am J Physiol
Gastrointest Liver Physiol. 299:G196–G204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeong YK, Lee S, Lim JW and Kim H:
Docosahexaenoic acid inhibits cerulein-induced acute pancreatitis
in rats. Nutrients. 9:E7442017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang HL, Tang GD, Liang ZH, Qin MB, Wang
XM, Chang RJ and Qin HP: Role of Wnt/β-catenin pathway agonist
SKL2001 in Caerulein-induced acute pancreatitis. Can J Physiol
Pharmacol. 97:15–22. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morrione A, Navarro M, Romano G, Dews M,
Reiss K, Valentinis B, Belletti B and Baserga R: The role of the
insulin receptor substrate-1 in the differentiation of rat
hippocampal neuronal cells. Oncogene. 20:4842–4852. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
DiMagno MJ, Williams JA, Hao Y, Ernst SA
and Owyang C: Endothelial nitric oxide synthase is protective in
the initiation of caerulein-induced acute pancreatitis in mice. Am
J Physiol Gastrointest Liver Physiol. 287:G80–G87. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye J, Jiang R, Cui M, Zhu B, Sun L, Wang
Y, Zohaib A, Dong Q, Ruan X, Song Y, et al: Etanercept reduces
neuroinflammation and lethality in mouse model of Japanese
encephalitis. J Infect Dis. 210:875–889. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen X, Duan Y, Riley AM, Welch MA, White
FA, Grant MB and Obukhov AG: Long-term diabetic microenvironment
augments the decay rate of capsaicin-induced currents in mouse
dorsal root ganglion neurons. Molecules. 24:7752019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fernandez R and Maecker H:
Cytokine-stimulated Phosphoflow of PBMC using CyTOF mass cytometry.
Bio Protoc. 5:e14962015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi Q, Liao KS, Zhao KL, Wang WX, Zuo T,
Deng WH, Chen C, Yu J, Guo WY, He XB, et al: Hydrogen-rich saline
attenuates acute renal injury in sodium taurocholate-induced severe
acute pancreatitis by inhibiting ROS and NF-κB pathway. 2015.
6850432015.PubMed/NCBI
|
|
36
|
Karin M and Ben-Neriah Y: Phosphorylation
meets ubiquitination: The control of NF-[kappa]B activity. Ann Rev
Immunol. 18:621–663. 2000. View Article : Google Scholar
|
|
37
|
Pitchumoni CS, Agarwal N and Jain NK:
systemic complications of acute-pancreatitis. Am J Gastroenterol.
83:597–606. 1988.PubMed/NCBI
|
|
38
|
Sharma V, Sharma R, Rana SS and Bhasin DK:
Pancreatic encephalopathy: An unusual cause of asterixis. JOP.
15:383–384. 2014.PubMed/NCBI
|
|
39
|
Zhuan L and Zhaoshen L: Progress in
Pancreatic Encephalopathy. Pancreatology. 4:248–250. 2003.
|
|
40
|
Parlar A, Arslan SO, Doğan MF, Çam SA,
Yalçin A, Elibol E, Özer MK, Üçkardeş F and Kara H: The exogenous
administration of CB2 specific agonist, GW405833, inhibits
inflammation by reducing cytokine production and oxidative stress.
Exp Ther Med. 16:4900–4908. 2018.PubMed/NCBI
|
|
41
|
Dantzer R, O'Connor JC, Freund GG, Johnson
RW and Kelley KW: From inflammation to sickness and depression:
When the immune system subjugates the brain. Nat Rev Neurosci.
9:46–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Song C and Wang H: Cytokines mediated
inflammation and decreased neurogenesis in animal models of
depression. Prog Neuropsychopharmacol Biol Psychiatry. 35:760–768.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Habtezion A: Inflammation in acute and
chronic pancreatitis. Curr Opin Gastroenterol. 31:395–399. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu Y and Li Y, Chen KL, Zhou B, Lv ZY,
Zhou ZG and Li Y: Knockdown of Myeloid differentiation factor 88
attenuates lipopolysaccharide-induced inflammatory response in
pancreatic ductal cells. Pancreas. 45:755–760. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yan EB, Hellewell SC, Bellander BM,
Agyapomaa DA and Morganti-Kossmann MC: Post-traumatic hypoxia
exacerbates neurological deficit, neuroinflammation and cerebral
metabolism in rats with diffuse traumatic brain injury. J
Neuroinflamm. 8:1472011. View Article : Google Scholar
|
|
46
|
Farrokhi M, Etemadifar M, Jafary Alavi MS,
Zarkesh-Esfahani SH, Behjati M, Rezaei A and Amani-Beni A:
TNF-alpha production by peripheral blood monocytes in multiple
sclerosis patients and healthy controls. Immunol Invest.
44:590–601. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gallitano SM, McDermott L, Brar K and
Lowenstein E: Use of tumor necrosis factor (TNF) inhibitors in
patients with HIV/AIDS. J Am Acad Dermatol. 74:974–980. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kinra P and Dutta V: Serum TNF alpha
levels: A prognostic marker for assessment of severity of malaria.
Trop Biomed. 30:645–653. 2013.PubMed/NCBI
|
|
49
|
Yoshio T, Okamoto H, Kurasawa K, Dei Y,
Hirohata S and Minota S: IL-6, IL-8, IP-10, MCP-1 and G-CSF are
significantly increased in cerebrospinal fluid but not in sera of
patients with central neuropsychiatric lupus erythematosus. Lupus.
25:997–1003. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Witwer KW, Sarbanes SL, Liu J and Clements
JE: A plasma microRNA signature of acute lentiviral infection:
Biomarkers of central nervous system disease. AIDS. 25:2057–2067.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Paleolog EM, Young S, Stark AC, McCloskey
RV, Feldmann M and Maini RN: Modulation of angiogenic vascular
endothelial growth factor by tumor necrosis factor alpha and
interleukin-1 in rheumatoid arthritis. Arthritis Rheum.
41:1258–1265. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tétreault MP, Weinblatt D, Ciolino JD,
Klein-Szanto AJ, Sackey BK, Twyman-Saint Victor C, Karakasheva T,
Teal V and Katz JP: Esophageal expression of active IκB Kinase-β in
mice up-regulates tumor necrosis factor and granulocyte-macrophage
colony-stimulating factor, promoting inflammation and angiogenesis.
Gastroenterology. 150:1609–1619.e11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Pober JS, Gimbrone MA Jr, Lapierre LA,
Mendrick DL, Fiers W, Rothlein R and Springer TA: Overlapping
patterns of activation of human endothelial cells by interleukin 1,
tumor necrosis factor, and immune interferon. J Immunol.
137:1893–1896. 1986.PubMed/NCBI
|
|
54
|
Lupia E, Montrucchio G, Battaglia E,
Modena V and Camussi G: Role of tumor necrosis factor-alpha and
platelet-activating factor in neoangiogenesis induced by synovial
fluids of patients with rheumatoid arthritis. Eur J Immunol.
26:1690–1694. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Strieter RM, Kunkel SL, Showell HJ, Remick
DG, Phan SH, Ward PA and Marks RM: Endothelial cell gene expression
of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1
beta. Science. 243:1467–1469. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sui Y, Lee JH, DiMicco MA, Vanderploeg EJ,
Blake SM, Hung HH, Plaas AH, James IE, Song XY, Lark MW and
Grodzinsky AJ: Mechanical injury potentiates proteoglycan
catabolism induced by interleukin-6 with soluble interleukin-6
receptor and tumor necrosis factor alpha in immature bovine and
adult human articular cartilage. Arthritis Rheum. 60:2985–2996.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yuan JT, Wang L, Lin YJ, Chen JH and Hu
JH: Differences of plasma IL-1 and TNF-α in healthy Chinese
population. Open Med (Wars). 10:306–310. 2015.PubMed/NCBI
|
|
58
|
Ishitsuka Y, Kawachi Y, Maruyama H,
Taguchi S, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y and Otsuka F:
Pituitary tumor transforming gene 1 induces tumor necrosis factor-α
production from keratinocytes: Implication for involvement in the
pathophysiology of psoriasis. J Invest Dermatol. 133:2566–2575.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Dayer JM, Beutler B and Cerami A:
Cachectin/tumor necrosis factor stimulates collagenase and
prostaglandin E2 production by human synovial cells and dermal
fibroblasts. J Exp Med. 162:2163–2168. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Fisic E, Poropat G, Bilic-Zulle L, Licul
V, Milic S and Stimac D: The role of IL-6, 8, and 10, sTNFr, CRP,
and pancreatic elastase in the prediction of systemic complications
in patients with acute pancreatitis. Gastroenterol Res Pract.
2013:2826452013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xue D, Zhang W, Zhang Y, Wang H, Zheng B
and Shi X: Adjusting effects of baicalin for nuclear Factor-kappa B
and tumor necrosis factor-alpha on rats with caerulein-induced
acute pancreatitis. Mediat Inflamm. 2006:262952006. View Article : Google Scholar
|
|
62
|
Otsuka Y, Kamata K, Minaga K, Takenaka M,
Watanabe T and Kudo M: Acute pancreatitis with disturbed
consciousness caused by hyperparathyroidism. Intern Med.
57:3075–3078. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Miller AH, Maletic V and Raison CL:
Inflammation and its discontents: The role of cytokines in the
pathophysiology of major depression. Biol Psychiat. 65:732–741.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Scott LJ: Etanercept: A review of its use
in autoimmune inflammatory diseases. Drugs. 74:1379–1410. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hobbs K, Deodhar A, Wang B, Bitman B,
Nussbaum J, Chung J and Collier DH: Randomized, double-blind,
placebo-controlled study to evaluate the efficacy and safety of
etanercept in patients with moderately active rheumatoid arthritis
despite DMARD therapy. Springerplus. 4:1132015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Mease PJ, Gladman DD, Collier DH, Ritchlin
CT, Helliwell PS, Liu L, Kricorian G and Chung JB: Etanercept and
methotrexate as monotherapy or in combination for psoriatic
arthritis: Primary results from a randomized, controlled phase III
trial. Arthritis Rheumatol. 71:1112–1124. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Soyalp M, Yalcin M, Oter V and Ozgonul A:
Investigation of procalcitonin, IL-6, oxidative stress index (OSI)
plasma and tissue levels in experimental mild and severe
pancreatitis in rats. Bratisl Lek Listy. 118:137–141.
2017.PubMed/NCBI
|
|
68
|
Horowitz MA, Wertz J, Zhu D, Cattaneo A,
Musaelyan K, Nikkheslat N, Thuret S, Pariante CM and Zunszain PA:
Antidepressant compounds can be both pro- and anti-inflammatory in
human hippocampal cells. Int J Neuropsychopharmacol. 18:pyu0762014.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Giles JT, Sattar N, Gabriel S, Ridker PM,
Gay S, Warne C, Musselman D, Brockwell L, Shittu E, Klearman M and
Fleming TR: cardiovascular safety of tocilizumab versus etanercept
in rheumatoid arthritis: A randomized controlled trial. Arthritis
Rheumatol. 72:31–40. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Smith KM, Amin S, Jones LK Jr, Lachance
DH, Flanagan EP, Jentoft ME and Kantarci OH: Glial fibrillary
acidic protein (GFAP) autoimmunity in the setting of seropositive
rheumatoid arthritis treated with etanercept. Neurologist.
24:152–154. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Pham CH, Gillenwater TJ, Nagengast E,
McCullough MC, Peng DH and Garner WL: Combination therapy:
Etanercept and intravenous immunoglobulin for the acute treatment
of Stevens-Johnson syndrome/toxic epidermal necrolysis. Burns.
45:1634–1638. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yang J, He F, Meng Q, Sun Y, Wang W and
Wang C: Inhibiting HIF-1α decreases expression of TNF-α and
caspase-3 in specific brain regions exposed kainic acid-induced
status epilepticus. Cell Physiol Biochem. 38:75–82. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Genet GF, Bentzer P, Hansen MB, Ostrowski
SR and Johansson PI: Effects of propranolol and clonidine on brain
edema, blood-brain barrier permeability, and endothelial glycocalyx
disruption after fluid percussion brain injury in the rat. J Trauma
Acute Care Surg. 84:89–96. 2018. View Article : Google Scholar : PubMed/NCBI
|